Tenet (THC) Reports Q3 Earnings: What Key Metrics Have to Say

Zacks
Abrir en Zacks
Tenet (THC) Reports Q3 Earnings: What Key Metrics Have to Say

Tenet Healthcare (THC) reported $5.63 billion in revenue for the quarter ended September 2026, representing a year-over-year increase of 6.5%. EPS of $6.64 for the same period compares to $3.70 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $5.47 billion, representing a surprise of +2.87%. The company delivered an EPS surprise of +44.35%, with the consensus EPS estimate being $4.60.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Tenet performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Ambulatory Care- Net revenue per case: 6.1% compared to the 5.1% average estimate based on three analysts. Ambulatory Care- Cases: -1.5% compared to the -0.7% average estimate based on three analysts. Adjusted patient admissions - Same-hospital: 222.2 thousand versus 216.15 thousand estimated by two analysts on average. Net patient service revenue per adjusted patient admission - Same Hospital: $16,071.00 versus the two-analyst average estimate of $16,424.59. Adjusted admissions: 223.64 thousand versus 213.91 thousand estimated by two analysts on average. Net Operating revenues: $5.63 billion versus $5.47 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +6.5% change. Net Operating revenues- Ambulatory Care: $1.37 billion versus $1.38 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +7.5% change. Net Operating revenues- Hospital Operations and Services: $4.26 billion compared to the $4.09 billion average estimate based on four analysts. The reported number represents a change of +6.1% year over year. Hospital Operations- Net patient service revenues from hospitals and related outpatient facilities: $3.59 billion versus $3.48 billion estimated by two analysts on average. Adjusted EBITDA- Hospital Operations and Services: $818 million versus $629.45 million estimated by three analysts on average. Equity in earnings of unconsolidated affiliates- Ambulatory Care: $64 million versus $67.91 million estimated by three analysts on average. Adjusted EBITDA- Ambulatory Care: $537 million versus $537.76 million estimated by three analysts on average.

View all Key Company Metrics for Tenet here>>>

Shares of Tenet have returned +5.1% over the past month versus the Zacks S&P 500 composite's +0.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Tenet Healthcare Corporation (THC): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research